Sélecteurs génériques
Correspondances exactes uniquement
Rechercher dans le titre
Rechercher dans le contenu
Sélecteurs de types de messages
Contact

Développement rapide des capacités aseptiques : comment les méthodes de construction modernes soutiennent les services pharmaceutiques du NHS

10 juin, 2026
< Retour aux actualités
Le défi est clair : comment les organismes du NHS peuvent-ils accroître ou moderniser rapidement, en toute sécurité et sans perturber les services essentiels, leurs capacités en matière d’asepsie ?

Across the NHS, the demand for aseptic services continues to grow.

From chemotherapy and CIVAS to TPN and radiopharmacy, the need for safe, compliant and efficient aseptic preparation is increasing, driven by rising patient demand, more complex therapies and the continued shift towards centralised and high-quality compounding.

At the same time, many pharmacy departments are operating within infrastructure that was not designed to meet today’s requirements.

Le défi est clair : comment les organismes du NHS peuvent-ils accroître ou moderniser rapidement, en toute sécurité et sans perturber les services essentiels, leurs capacités en matière d’asepsie ?

A growing pressure on aseptic services

Aseptic units are some of the most technically demanding environments within healthcare.

They must meet stringent regulatory requirements, including:

  • GMP compliance for aseptic preparation
  • ISO classifications for cleanroom environments
  • Controlled airflow, pressure regimes and environmental monitoring
  • Robust validation and quality assurance processes

Many existing facilities are facing:

  • Capacity constraints
  • Ageing infrastructure
  • Challenges in maintaining compliance during refurbishment
  • Limited flexibility to scale services

In some cases, this leads to delays in treatment, increased outsourcing, or operational inefficiencies.

The infrastructure challenge

Upgrading or expanding aseptic facilities within a live hospital environment is complex.

Traditional construction approaches can:

  • Take significant time to deliver
  • Disrupt existing pharmacy operations
  • Require decanting of services
  • Introduce compliance risks during refurbishment

For critical services such as chemotherapy or radiopharmacy, downtime is not an option.

This is where a different approach is required.

A modern approach to cleanroom delivery

Modern Methods of Construction (MMC) offer a practical alternative.

By combining offsite manufacturing with on-site integration, MMC enables the delivery of fully compliant aseptic cleanroom facilities more efficiently and with reduced disruption.

For NHS organisations, this means:

  • Faster deployment of new capacity
  • Reduced impact on existing services
  • Greater consistency in build quality
  • Improved coordination of complex cleanroom environments

Facilities can be designed to meet specific requirements for:

  • CIVAS, chemotherapy and TPN compounding
  • Radiopharmacy applications
  • GMP-compliant cleanroom classifications
  • Integrated equipment, including isolators and laminar airflow systems
  • Designed for compliance and performance

Aseptic cleanrooms delivered through MMC are not simply modular spaces.

They are fully engineered clinical environments, designed to meet:

  • EU GMP Annex 1 requirements
  • ISO cleanroom standards
  • MHRA expectations for aseptic preparation

This includes:

  • Controlled airflow and pressure cascades
  • High-efficiency particulate air (HEPA) filtration
  • Environmental monitoring systems
  • Integrated utilities and services

The result is a facility that supports both regulatory compliance and operational efficiency.

Supporting continuity during change

One of the key advantages of this approach is flexibility.

Facilities can be used to:

  • Provide additional capacity alongside existing units
  • Support service expansion
  • Enable decant during refurbishment of permanent facilities
  • Maintain continuity of critical aseptic services

This is particularly valuable where existing infrastructure requires upgrade but services must remain operational.

A flexible approach to delivery and funding

Recognising the financial pressures facing the NHS, Vanguard Life Sciences offers a range of flexible options.

Ceux-ci inclus:

  • Rental models for short or medium-term requirements
  • Purchase options for long-term infrastructure investment
  • Facility Flex solutions, allowing organisations to align funding with operational and capital budgets

This flexibility enables organisations to respond to immediate pressures while planning for longer-term estate strategy.

A trusted partner in healthcare infrastructure

As part of Solutions de soins de santé Vanguard, Vanguard Life Sciences brings extensive experience in delivering high-quality clinical environments across the NHS.

Our approach is fully turnkey, supporting organisations from initial design and planning through to delivery, commissioning and validation.

This ensures that facilities are not only delivered quickly, but also meet the highest standards of safety, compliance and performance.

Perspectives d'avenir

The demand for aseptic services will continue to grow.

Meeting that demand requires infrastructure that is flexible, compliant and capable of adapting to future needs.

Modern Methods of Construction provide a practical route to achieving this, enabling NHS organisations to expand capacity at pace while maintaining the highest standards of care.

Download the brochure to learn more about Vanguard Life Sciences aseptic cleanroom solutions.

Partagez ceci :

< Retour aux actualités

Tu pourrais aussi aimer...

Vanguard Sciences de la vie : Soutenir le plan sectoriel des sciences de la vie du Royaume-Uni grâce à des infrastructures avancées

Le plan sectoriel du gouvernement britannique pour les sciences de la vie définit une feuille de route ambitieuse visant à renforcer la position du pays en tant que leader mondial dans les domaines pharmaceutique, biotechnologique et de l'innovation médicale.
En savoir plus

Infrastructures à prendre en compte pour vos demandes de financement au Fonds d'investissement britannique pour la R&D transformationnelle en sciences de la vie

Le Fonds d'investissement transformationnel en recherche et développement des sciences de la vie du gouvernement britannique représente une opportunité historique pour les organisations qui font progresser l'innovation dans les domaines pharmaceutique, biotechnologique et de la recherche médicale.
En savoir plus

Vanguard Sciences de la vie
Unité 1144 Regent Court, The Square, Gloucester Business Park, Gloucester, GL3 4AD

crossmenu